期刊文献+

临床决策中如何科学运用cNCCN治疗指南

下载PDF
导出
摘要 内分泌治疗在乳腺癌辅助治疗中具有重要地位,毒副反应较轻,有利于长期治疗,中国乳腺癌临床实践指南(cNCCN)对可切除早期乳腺癌术后辅助治疗原则有详细阐述,但临床使用中还会面临某些具体问题。本文结合临床实践中乳腺癌术后辅助内分泌治疗所面临的实际问题和治疗决策,分析在临床实践中如何科学运用指南和解决某些重要的指南内外的具体问题。
出处 《中国肿瘤外科杂志》 CAS 2009年第6期321-322,326,共3页 Chinese Journal of Surgical Oncology
  • 相关文献

参考文献5

  • 1Howell A,Cuzick J,Baum M,et al.Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer[].LancetThe.2005
  • 2Boccardo F,Rubagotti A,Guglielmini P,Fini A,Paladini G,Mesiti M,Rinaldini M,Scali S,Porpiglia M,Benedetto C,Restuccia N,Buzzi F,Franchi R,Massidda B,Distante V,Amadori D,Sismondi P.Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial[].Annals of oncology : official journal of the European Society for Medical Oncology / ESMO.2006
  • 3Early Breast Cancer Trialists’ Collaborative Group (EBCTCG).Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials[].LancetThe.2005
  • 4Michelle D Althuis,Jaclyn M Dozier,William F Anderson,Susan S Devesa,Louise A Brinton.Global trends in breast cancer incidence and mortality 19731997[].International Journal of Epidemiology.2005
  • 5Baum M,Buzdar A,Cuzick J,et al.Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early-stage breast cancer: results of the ATAC (Arimidex, Tamoxifen Alone or in Combination) trial efficacy and safety update ana[].Cancer.2003

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部